News from Portfolio Companies

New Ventures News and Publications

  • Gini Deshpande of NuMedii on Augmented Intelligence for Drug Discovery
    Episode Summary This week Harry talks with Gini Deshpande, the co-founder and CEO of San Mateo, CA-based NuMedii, a company making judicious use of big data and AI to speed up drug discovery. Episode Notes Gini Desphande says she likes to think of “AI” as augmented intelligence rather than artificial intelligence: a system of human plus machine intelligence that can ...
  • Chris Boone of Pfizer on Being a Data Hippie
    Episode Summary This week Harry talks with Chris Boone, a leader of Pfizer’s effort to use new types of real-world data on patients—from insurance claims to lab tests to molecular profiles to data from wearable health sensor—to speed up drug discovery, development, and testing. Episode Notes Dr. Chris Boone, vice president and lead for global medical epidemiology and big data ...
  • ADC THERAPEUTICS FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING
    Lausanne, Switzerland — September 6, 2019 — ADC Therapeutics SA, a clinical-stage oncology-focused biotechnology company pioneering the development of highly potent and targeted antibody drug conjugates for patients suffering from hematological malignancies and solid tumors, announced today that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public ...
  • Kevin Tabb of Beth Israel Lahey Health on How to Get Ahead of Change in Healthcare
    EPISODE SUMMARY Harry talks with the CEO and president of Beth Israel Lahey Health, the product of Lahey Health’s merger this spring with Beth Israel Deaconess Medical Center and several other hospitals in the Boston region. How does Dr. Tabb manage change inside a growing organization that—by his own admission—has to build and implement new tools, processes and the actionable ...
  • Peter Coffee and Salesforce’s Vision for the Platformization of Healthcare
    Summary Harry talks this week with Salesforce’s vice president of strategic research, Peter Coffee. The computer-industry veteran and former tech columist says that in the era of 1) outcomes-based payments for medical care, 2) an aging patient base, and 3) ubiquitous sensors and continuous data collection, there’s a huge opportunity—and financial incentive—for healthcare providers to employ technology platforms that improve ...
  • Rhoda Au on Digital Biomarkers and Precision Brain Health
    Summary Harry speaks with Boston University’s Rhoda Au, who believes that algorithms parsing new kinds of digital data about individual patients could find warning signs of diseases like dementia while they’re still preventable—leading to a new era in which precision medicine is gradually replaced by “precision health.” Episode Notes As one of the researchers involved in the 70-year-long Framingham Heart ...
  • Kathryn Teng on Unlocking the Puzzle of Population Health
    Summary Harry has a heart-to-heart conversation with Dr. Kathryn Teng, who’s working to use data to implement an access- and experience-based population health model at MetroHealth, the public health system for Cuyahoga County, Ohio. Episode Notes Kathryn Teng, MD, is division chief of internal medicine and community medicine at MetroHealth, one of three major healthcare systems serving Cleveland and the ...
  • Alán Aspuru-Guzik and the Revolution in Molecular Design
    Summary Harry gets an update on the merger of AI, robotics, and high-throughput chemistry in the new “self-driving laboratory” from University of Toronto theoretical chemist Alán Aspuru-Guzik. Episode Notes Many of the processes carried out in traditional chemistry labs searching for new drugs or drug targets can be sped up through factory-style automation—and in fact, “combinatorial chemistry” was a big ...
  • Jennifer Carter and the Power of Individualized Cancer Care
    SHOW NOTES Dr. Jennifer Carter says it was watching friends and family members stricken with cancer struggle navigate the complexities of the healthcare system in the early 2000s that inspired her to start a company in the area of precision medicine. At that time, the development of targeted therapies for cancers with specific genetic markers was already offering new hope ...
  • Aalpen Patel and Using AI to Reduce Time-to-Diagnosis (AI World Special Series Part 1)
    EPISODE SUMMARY: What if we could use machine learning to train software to read CT scans of patients with intracranial hemorrhaging? Time to diagnosis could be doubled, potentially saving lives. This week Harry discusses such questions with Dr. Aalpen Patel, a physician-engineer who chairs Geisinger’s department of radiology and directs is 3D imaging and printing laboratory. This episode is the ...